Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Phase II Study to Assess the Efficacy and Safety of Eltrombopag for the Treatment of Children and Adolescents With Fanconi Anemia.

NCT06045052 is registered in ClinicalTrials.gov with Julian Sevilla as lead sponsor.

NCT NCT06045052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06045052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Phase II Study to Assess the Efficacy and Safety of Eltrombopag for the Treatment of Children and Adolescents With Fanconi Anemia.
Lead sponsor
Julian Sevilla
Phase
Phase 2
Overall status
Completed
Start date
December 2, 2020
Completion date
August 29, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fanconi anemia